Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX7K3C
|
||||
Drug Name |
3R-(2-oxo-1-(2-oxo-2-(4-oxopent-2-enylamino)ethyl)-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)methyl 4-chloro-2-(trifluoromethyl)phenylcarbamate
|
||||
Synonyms |
CHEMBL509518
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C31H26ClF3N4O5
|
||||
Canonical SMILES |
CC(=O)\\C=C\\CNC(=O)CN1C(=O)[C@@H](COC(=O)Nc2ccc(Cl)cc2C(F)(F)F)N=C(c3ccccc3)c4ccccc14
|
||||
InChI |
InChI=1S/C31H26ClF3N4O5/c1-19(40)8-7-15-36-27(41)17-39-26-12-6-5-11-22(26)28(20-9-3-2-4-10-20)37-25(29(39)42)18-44-30(43)38-24-14-13-21(32)16-23(24)31(33,34)35/h2-14,16,25H,15,17-18H2,1H3,(H,36,41)(H,38,43)/b8-7+/t25-/m1/s1
|
||||
InChIKey |
TWBMCOZHTPQAMF-LAUDKDLHSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.